Long-term biodistribution in vivo and toxicity of radioactive/magnetic hydroxyapatite nanorods.

Although nanoscale hydroxyapatite [Ca10(PO4)6(OH)2; HA] has been widely investigated as a carrier in the delivery of drugs, genes, or siRNA, the in vivo toxicity of nanoscale HA is not clear and the long-term dynamic distribution in vivo has not hitherto been visualized. In this work, gadolinium-doped HA nanorods (HA:Gd) with an r1 value of 5.49 s(-1) (mm)(-1) have been prepared by a hydrothermal method. Samarium-153 ((153)Sm) was then effectively post-labeled onto the HA:Gd ((153)Sm-HA:Gd) with a labeling rate of ∼100% and a radio-labeling stability in vitro of ∼100% over 48 h. The product could serve as a new dual-modality probe for SPECT and MR imaging in vivo. By means of SPECT and MRI, the HA:Gd nanorods were found to be quickly taken up by the mononuclear phagocyte system, especially the liver and spleen. The nanorods in the liver and lung tended to be eliminated within 24 h, but nanorods in the spleen behaved differently and proved difficult to excrete. In vitro studies by cell transmission electron microscopy (TEM) and methyl thiazolyl tetrazolium (MTT) assay showed good biocompatibility of the HA:Gd nanorods with HeLa cells, even at a high concentration. The indicators of body weight, histology, and serology demonstrated that the HA:Gd nanorods exhibited excellent biocompatibility in vivo for at least 61 days. Therefore, (153)Sm-HA:Gd nanorods with excellent relaxivity, γ-emission, and biosafety offer clear advantages and potential for bioapplications.

[1]  Matthias Epple,et al.  Biological and medical significance of calcium phosphates. , 2002, Angewandte Chemie.

[2]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[3]  A. Sbarbati,et al.  High field MRI in preclinical research. , 2003, European journal of radiology.

[4]  En Ma,et al.  Amine-functionalized lanthanide-doped zirconia nanoparticles: optical spectroscopy, time-resolved fluorescence resonance energy transfer biodetection, and targeted imaging. , 2012, Journal of the American Chemical Society.

[5]  L. Zichner,et al.  Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. , 2005, Biomaterials.

[6]  R. A. Holmes,et al.  Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Jun Lin,et al.  Solvothermal synthesis and characterization of Ln (Eu3+, Tb3+) doped hydroxyapatite. , 2008, Journal of colloid and interface science.

[8]  D. Meier,et al.  Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[9]  Jun Lin,et al.  Functionalized mesoporous silica materials for controlled drug delivery. , 2012, Chemical Society reviews.

[10]  I. Cullum,et al.  Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Qian Liu,et al.  18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. , 2011, ACS nano.

[12]  James H. Adair,et al.  Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. , 2008, Nano letters.

[13]  Yun Sun,et al.  Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. , 2011, Biomaterials.

[14]  Zhi-su Liu,et al.  Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. , 2003, World journal of gastroenterology.

[15]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[16]  Alexandra E. Ewence,et al.  Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells: A Potential Mechanism in Atherosclerotic Plaque Destabilization , 2008, Circulation research.

[17]  E. Hollande,et al.  Europium-doped bioapatite: a new photostable biological probe, internalizable by human cells. , 2003, Biomaterials.

[18]  Masahiro Yoshimura,et al.  Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants , 1998 .

[19]  Samuel I. Stupp,et al.  Biomimetic Systems for Hydroxyapatite Mineralization Inspired by Bone and Enamel , 2009 .

[20]  Larry L. Hench,et al.  Bioceramics: From Concept to Clinic , 1991 .

[21]  S. Meikle,et al.  Small animal SPECT and its place in the matrix of molecular imaging technologies , 2005, Physics in medicine and biology.

[22]  L. Grover,et al.  Silver-doped calcium phosphate cements with antimicrobial activity. , 2011, Acta biomaterialia.

[23]  Wei Feng,et al.  Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,153Sm nanoparticles for blood pool imaging in vivo. , 2013, Biomaterials.

[24]  Jun Lin,et al.  Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. , 2008, Biomaterials.

[25]  James H. Adair,et al.  Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[26]  Lili Wang,et al.  Multifunctional hydroxyapatite nanofibers and microbelts as drug carriers. , 2009, Chemistry.

[27]  Yongsheng Liu,et al.  Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications. , 2013, Chemical Society reviews.

[28]  J. Stafford,et al.  Evaluating the toxicity of hydroxyapatite nanoparticles in catfish cells and zebrafish embryos. , 2013, Small.

[29]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[30]  Wei Feng,et al.  Radioisotope post-labeling upconversion nanophosphors for in vivo quantitative tracking. , 2013, Biomaterials.

[31]  Matthias Epple,et al.  Application of calcium phosphate nanoparticles in biomedicine , 2010 .

[32]  C. Rey,et al.  Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. , 2010, Acta biomaterialia.

[33]  Yun Sun,et al.  Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. , 2010, Biomaterials.

[34]  A. Lebugle,et al.  Synthesis of luminescent bioapatite nanoparticles for utilization as a biological probe , 2004 .

[35]  Y. Liu,et al.  Hydrothermal synthesis of NaLuF4:153Sm,Yb,Tm nanoparticles and their application in dual-modality upconversion luminescence and SPECT bioimaging. , 2013, Biomaterials.

[36]  Yongsheng Liu,et al.  Lanthanide-Doped Luminescent Nanoprobes: Controlled Synthesis, Optical Spectroscopy, and Bioapplications , 2013 .

[37]  J. Skepper,et al.  Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. , 2009, Biomaterials.

[38]  Bradley E Patt,et al.  Rationale for the Combination of Nuclear Medicine with Magnetic Resonance for Pre-clinical Imaging , 2006, Technology in cancer research & treatment.

[39]  T. Webster,et al.  Osteoblast response to hydroxyapatite doped with divalent and trivalent cations. , 2004, Biomaterials.

[40]  James H. Adair,et al.  Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. , 2008, Nano letters.

[41]  Ying-Jie Zhu,et al.  Multifunctional Eu3+/Gd3+ dual-doped calcium phosphate vesicle-like nanospheres for sustained drug release and imaging. , 2012, Biomaterials.

[42]  Wei Zheng,et al.  Sub-10 nm lanthanide-doped CaF2 nanoprobes for time-resolved luminescent biodetection. , 2013, Angewandte Chemie.